Electroacupoint for Diminutive Milk Production

NCT ID: NCT06590805

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to reveal the effect of electroacupoint on scanty milk production in lactating women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postnatal scanty milk secretion is a common complaint. Some physical and medicinal therapies have been proposed to enhance milk production. These therapies must be both successful and safe for both the mother and the child. In many cases, milk supply can be increased by frequent, regular milk removal, Medication to increase milk supply (galactogogues) such as domperidone.

Domperidone has been linked to maternal adverse effects in galactogogue trials and cases reported to the Food and Drug Administration include dry mouth, headache, dizziness, nausea, abdominal cramping, diarrhea, palpitations malaise, and shortness of breath. Some of these were more frequent with dosages greater than with 30 mg daily. Drug withdrawal symptoms consisting of insomnia, anxiety, and tachycardia were reported in a woman taking 80 mg of domperidone daily for 8 months as a galactogogue who abruptly tapered the dose over 3 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Therapy Electrotherapy Dietary Modification

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two Parallel Groups for Comparison.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electroacupoint combined with postnatal care

Electroacupoint stimulation using the Electroacupoint device and postnatal care diet in form of balanced diet and drinking sufficient clean water and routine postnatal care.

Group Type EXPERIMENTAL

Electrotherapy using Chattanooga stimulation unit

Intervention Type PROCEDURE

Electroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit 2783. It uses the influences energy flows by needling the acupuncture points which lie along the body meridians to achieve a harmonious balance between physical, emotional, and spiritual states. The same effect can be achieved without the use of needles. These needleless stimulations are noninvasive and nontraumatic and are useful for individuals who are scared of needles. They are also associated with decreased risk of infection or bruise.

Balanced Diet using domperidone drug, iron, and folic acid supplementation.

Intervention Type DIETARY_SUPPLEMENT

Postnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care.

It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.

postnatal care only

Postnatal care diet in form of balanced diet and drinking sufficient clean water and routine postnatal care.

Group Type ACTIVE_COMPARATOR

Balanced Diet using domperidone drug, iron, and folic acid supplementation.

Intervention Type DIETARY_SUPPLEMENT

Postnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care.

It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrotherapy using Chattanooga stimulation unit

Electroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit 2783. It uses the influences energy flows by needling the acupuncture points which lie along the body meridians to achieve a harmonious balance between physical, emotional, and spiritual states. The same effect can be achieved without the use of needles. These needleless stimulations are noninvasive and nontraumatic and are useful for individuals who are scared of needles. They are also associated with decreased risk of infection or bruise.

Intervention Type PROCEDURE

Balanced Diet using domperidone drug, iron, and folic acid supplementation.

Postnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care.

It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* They were complaining of insufficiency of lactation within the first month after cesarean section.
* They are using mixed feeding; both breast and bottle feeding, between three and six bottles per day.
* Their age ranged from 25-30 years old.
* Their body mass index didn't exceeded 30 kg/m2.

Exclusion Criteria

* Postpartum haemorrhage.
* Cardiorespiratory disease.
* Diabetes mellitus.
* Breast cancer.
* Previous surgeries in the chest, breast, or the surrounding area.
* Anemia.
* Any causes that hindered their normal breastfeeding (retraced, cracked, inflamed, or inverted nipples).
* Receiving contraceptive pills.
* Having infants with conditions that may affect the lactation process such as congenital abnormalities of the mouth (tongue tie, cleft palate).
* Congenital heart disease.
Minimum Eligible Age

25 Years

Maximum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Haytham Ibrahim Morsi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Haytham Ibrahim Morsi

Lecturer

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Haytham I Morsi, M.Sc.

Role: STUDY_DIRECTOR

Kafrelsheikh University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kafrelsheikh University

Kafrelsheikh, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sara E Seyam, B.Sc.

Role: CONTACT

+201554552868

Haytham I Morsi, M.Sc.

Role: CONTACT

+201013657738

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.1 993

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Breast Milk Olfactory Stimulation
NCT06771882 NOT_YET_RECRUITING NA